1.           Introduction

1.1         Scope Of The Study

1.2         The Insight Partners Research Report Guidance

2.           North America Narcolepsy Market – Key Takeaways

3.           North America Narcolepsy Market – Market Landscape

3.1         Overview

3.2         Market Segmentation

3.2.1        North America Narcolepsy Market – By Type

3.2.2        North America Narcolepsy Market – By Product

3.2.3        North America Narcolepsy Market – By Distribution Channel

3.2.4        North America Narcolepsy Market – By Country

3.3         Pest Analysis

4.           North America Narcolepsy Market-Key Dynamics

4.1         Key Market Drivers

4.1.1        Rising Sleep Disorders

4.1.2        Growing Pharmaceutical Industry

4.2         Key Market Restraints

4.2.1        No Cure Treatment for Narcolepsy

4.3         Key Market Opportunity

4.3.1        Awareness Programs for Narcolepsy

4.4         Future Trend

4.4.1        Developments in Pharmaceutical Sector to Treat Narcolepsy

4.5         Impact Analysis Of Drivers and Restraints

5.           Narcolepsy Market – Regional Analysis

5.1         North America Narcolepsy Market Revenue Forecasts and Analysis

5.2         Performance Of Key Players

5.2.1        Jazz Pharmaceuticals plc

5.2.2        Teva Pharmaceutical Industries Ltd.

6.           Narcolepsy Market Analysis and Forecasts to 2027 – Type

6.1         Overview

6.2         Type Market Revenue and Forecasts Analysis (US$ Mn)

6.3         North America Narcolepsy With Cataplexy Market Revenue and Forecasts To 2027, By Type (Us$ Mn)

6.4         Narcolepsy With Cataplexy Market

6.4.1        Overview

6.4.2        Narcolepsy With Cataplexy Market Revenue and Forecast to 2027 (US$ Mn)

6.5         Narcolepsy Without Cataplexy Market

6.5.1        Overview

6.5.2        Narcolepsy Without Cataplexy Market Revenue and Forecast to 2027 (US$ Mn)

6.6         Secondary Narcolepsy Market

6.6.1        Overview

6.6.2        Secondary Narcolepsy Market Revenue and Forecast to 2027 (US$ Mn)

7.           Narcolepsy Market Analysis and Forecasts to 2027 – Product

7.1         Overview

7.2         Product Market Revenue and Forecasts Analysis (US$ Mn)

7.3         North America Narcolespy Market Revenue and Forecasts To 2027, By Product (US$ Mn)

7.4         Central Nervous System Stimulants Market

7.4.1        Overview

7.4.2        Central Nervous System Stimulants Market Revenue and Forecast to 2027 (US$ Mn)

7.5         Sodium Oxybate Market

7.5.1        Overview

7.5.2        Sodium Oxybate Market Revenue and Forecast to 2027 (US$ Mn)

7.6         Antidepressants Market

7.6.1        Overview

7.6.2        Antidepressants Market Revenue and Forecast to 2027 (US$ Mn)

8.           Narcolepsy Market Analysis and Forecasts to 2027 – Distribution Channel

8.1         Overview

8.2         Distribution Channel Market Revenue and Forecasts Analysis (US$ Mn)

8.3         North America Narcolespy Market Revenue and Forecasts To 2027, By End User (US$ Mn)

8.4         Hospital Pharmacies Market

8.4.1        Overview

8.4.2        Hospital Pharmacies Market Revenue and Forecast to 2027 (US$ Mn)

8.5         Retail Pharmacies Market

8.5.1        Overview

8.5.2        Retail Pharmacies Market Revenue and Forecast to 2027 (US$ Mn)

9.           Narcolepsy Market Revenue And Forecasts To 2027 – Geographical Analysis

9.1         North America Narcolepsy Market

9.1.1        Overview

9.1.2        North America Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.3        North America Narcolepsy Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.4        North America Narcolepsy Market Revenue and Forecasts to 2027, By Product (US$ Mn)

9.1.5        North America Narcolepsy Market Revenue and Forecasts to 2027, By Distribution Channel (US$ Mn)

9.1.6        North America Narcolepsy Market Revenue and Forecasts to 2027, By Country (%)

9.1.7        US Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.8        US Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.8.1          US Narcolepsy Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.8.2          US Narcolepsy Market Revenue and Forecasts to 2027, By Product (US$ Mn)

9.1.8.3          US Narcolepsy Market Revenue and Forecasts to 2027, By Distribution Channel (US$ Mn)

9.1.9        Canada Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.10     Canada Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.10.1       Canada Narcolepsy Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.10.2       Canada Narcolepsy Market Revenue and Forecasts to 2027, By Product (US$ Mn)

9.1.10.3       Canada Narcolepsy Market Revenue and Forecasts to 2027, By Distribution Channel (US$ Mn)

9.1.11     Mexico Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.12     Mexico Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.12.1       Mexico Narcolepsy Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.12.2       Mexico Narcolepsy Market Revenue and Forecasts to 2027, By Product (US$ Mn)

9.1.12.3       Mexico Narcolepsy Market Revenue and Forecasts to 2027, By Distribution Channel (US$ Mn)

10.        Narcolepsy Market – Industry Landscape

10.1      Overview

10.2      Comparative Company Analysis

10.3      Growth Strategies Done By The Companies In The Market, (%)

10.4      Organic Developments

10.4.1     Overview

10.5      Inorganic Developments

10.5.1     Overview

11.        Narcolepsy Market –Key Company Profiles

11.1      Teva Pharmaceutical Industries Ltd.

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Financial Overview

11.1.4     Product Portfolio

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2      Jazz Pharmaceuticals Plc

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Financial Overview

11.2.4     Product Portfolio

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3      Arena Pharmaceuticals, Inc.

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Financial Overview

11.3.4     Product Portfolio

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4      Graymark Healthcare, Inc.

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Financial Information

11.4.4     Product Portfolio

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5      Novartis AG

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Financial Information

11.5.4     Product Portfolio

11.5.5     SWOT Analysis

11.5.6     Key Developments

11.6      Takeda Pharmaceutical Company Limited

11.6.1     Key Facts

11.6.2     Business Description

11.6.3     Financial Information

11.6.4     Product Pipeline

11.6.5     SWOT Analysis

11.6.6     Key Developments

11.7      Mylan N.V.

11.7.1     Key Facts

11.7.2     Business Description

11.7.3     Financial Overview

11.7.4     Product Portfolio

11.7.5     SWOT Analysis

11.7.6     Key Developments

11.8      Bioprojet

11.8.1     Key Facts

11.8.2     Business Description

11.8.3     Financial Overview

11.8.4     Product Portfolio

11.8.5     SWOT Analysis

11.8.6     Key Developments

11.9      Shionogi & Co., Ltd.

11.9.1     Key Facts

11.9.2     Business Description

11.9.3     Financial Overview

11.9.4     Product Portfolio

11.9.5     Product Pipeline

11.9.6     SWOT Analysis

11.9.7     Key Developments

11.10   Ligand Pharmaceuticals, Inc.

11.10.1  Key Facts

11.10.2  Business Description

11.10.3  Financial Overview

11.10.4  Product Portfolio

11.10.5  Product Pipeline

11.10.6  SWOT Analysis

11.10.7  Key Developments

12.        Appendix

12.1      About The Insight Partners

12.2      Glossary Of Terms

12.3      Methodology

12.3.1     Coverage

12.3.2     Secondary Research

12.3.3     Primary Research

LIST OF TABLES

Table 1.             North America Narcolepsy With Cataplexy Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 2.             North America Narcolepsy Market Revenue and Forecasts To 2027, By Product (US$ Mn)

Table 3.             North America Narcolepsy Market Revenue and Forecasts To 2027, By End User (US$ Mn)

Table 4.             North America Narcolepsy Market Revenue and Forecasts to 2027, By Type (US$ Mn)

Table 5.             North America Narcolepsy Market Revenue and Forecasts to 2027, By Product (US$ Mn)

Table 6.             North America Narcolepsy Market Revenue and Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 7.             US Narcolepsy Market Revenue and Forecasts to 2027, By Type (US$ Mn)

Table 8.             US Narcolepsy Market Revenue and Forecasts to 2027, By Product (US$ Mn)

Table 9.             US Narcolepsy Market Revenue and Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 10.          Canada Narcolepsy Market Revenue and Forecasts to 2027, By Type (US$ Mn)

Table 11.          Canada Narcolepsy Market Revenue and Forecasts to 2027, By Product (US$ Mn)

Table 12.          Canada Narcolepsy Market Revenue and Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 13.          Mexico Narcolepsy Market Revenue and Forecasts to 2027, By Type (US$ Mn)

Table 14.          Mexico Narcolepsy Market Revenue and Forecasts to 2027, By Product (US$ Mn)

Table 15.          Mexico Narcolepsy Market Revenue and Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 16.          Organic Developments Done By Companies

Table 17.          Inorganic Developments Done By Companies

Table 18.          Glossary of Terms, Narcolepsy Market

LIST OF FIGURES

Figure 1.           Us Narcolepsy Market, Revenue (Us$ Mn), 2018 & 2027

Figure 2.           North America Narcolepsy Market By Type, Market Share (%), 2018

Figure 3.           North America Narcolepsy Market By Product, Market Share (%), 2018

Figure 4.           North America Narcolepsy Market By Distribution Channel, Market Share (%), 2018

Figure 5.           Narcolepsy Market Segmentation

Figure 6.           North America Pest Analysis

Figure 7.           Narcolepsy Market Impact Analysis Of Drivers and Restraint

Figure 8.           North America Narcolepsy Market – Revenue Forecasts and Analysis – 2018- 2027

Figure 9.           Type Market Analysis and Forecasts 2018 and 2027 (%)

Figure 10.        Narcolepsy With Cataplexy Market Revenue and Forecasts To 2027 (US$ Mn)

Figure 11.        Narcolepsy Without Cataplexy Market Revenue and Forecasts To 2027 (US$ Mn)

Figure 12.        Secondary Narcolepsy Market Revenue and Forecasts To 2027 (US$ Mn)

Figure 13.        Product MARKET Analysis and Forecasts 2018 and 2027 (%)

Figure 14.        Central Nervous System Stimulants Market Revenue and Forecasts To 2027 (US$ Mn)

Figure 15.        Sodium Oxybate Market Revenue and Forecasts To 2027 (US$ Mn)

Figure 16.        Antidepressants Market Revenue and Forecasts To 2027 (US$ Mn)

Figure 17.        Distribution Channel Market Analysis and Forecasts 2018 and 2027 (%)

Figure 18.        Hospital Pharmacies Market Revenue and Forecasts To 2027 (US$ Mn)

Figure 19.        Retail Pharmacies Market Revenue and Forecasts To 2027 (US$ Mn)

Figure 20.        North America Narcolepsy Market Revenue Overview, By Country (2018) (Us $ Mn)

Figure 21.        North America Market Revenue and Forecasts To 2027 (US$ Mn)

Figure 22.        North America Narcolepsy Market Revenue and Forecasts To 2027, By Country (%)

Figure 23.        US Narcolepsy Market Revenue and Forecasts To 2027 (US$ Mn)

Figure 24.        Canada Narcolepsy Market Revenue and Forecasts To 2027 (US$ Mn)

Figure 25.        Mexico Narcolepsy Market Revenue and Forecasts To 2027 (US$ Mn)

Figure 26.        Comparative Company Analysis

Figure 27.        Growth Strategies Done By The Companies In The Market, (%)